DNA X, Inc.
corporate_fare Company Profile
DNA X, Inc. (NASDAQ:SONM) is a publicly traded company in the Manufacturing sector. Wiseek monitors SONM SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- DNA X Amends 8-K: $5.6M Series B Preferred Financing Lifts Pro Forma Equity Above Nasdaq Minimum
- DNA X Secures $8.1M Financing via Preferred Stock and Debt Conversion from Insider
- DNA X Terminates $500M Equity Purchase Agreement with Chardan Capital
- DNA X Receives Nasdaq Delisting Notice for Equity Non-Compliance
- Nasdaq Delisting Threat Looms as DNA X Secures $3.05M Convertible Note
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for SONM, detected from its recent SEC filings · based on capital-structure filings through 2026-07-02.
Secured $8.1 Million Financing · Insider-Led Capital Infusion
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →